Section 4.4 (special warnings and precautions for use) has been updated and now reads as follows:

Should paralytic ileus be suspected or occur during use, MST CONTINUS suspension should be discontinued immediately.  Patients about to undergo additional pain relieving procedures (e.g. surgery, plexus blockade) should not receive MST CONTINUS suspension for 24 hours prior to the intervention.  If further treatment with MST CONTINUS suspension is indicated, then the dosage should be adjusted to the new post-operative requirement.